Cantor Fitzgerald Biotech Analysts Kluska and Schmidt hold a conference call with CMO & EVP Crombez to discuss Osteogenesis Imperfecta (OI) on April 4 at 10:30 am. https://cantor.zoom.us/webinar/register/WN_p3Jp24VPRVSXlVM5VJjMQQ#/registration
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RARE:
- Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- JPMorgan ups Ultragenyx target, opens ‘Positive Catalyst Watch’ into data
- 3 Best Stocks to Buy Now, 3/15/2024, According to Top Analysts
- Ultragenyx to Participate at Investor Conferences in March
- Ultragenyx price target raised to $111 from $110 at TD Cowen